Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
155 studies found for:    dengue
Show Display Options
RSS Create an RSS feed from your search for:
dengue
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
81 Withdrawn TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant
Condition: Dengue
Interventions: Biological: TDENV-PIV;   Biological: TDENV-F17;   Other: Placebo
82 Completed Clinical Specimens Testing Program of Dengue Antigen Detection Reagents
Condition: Dengue Fever
Intervention:
83 Completed Adult Dengue Platelet Study
Condition: Dengue Fever
Interventions: Procedure: Platelet transfusion;   Other: Supportive care
84 Enrolling by invitation Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever
Intervention:
85 Recruiting The Use of Biomarkers in Predicting Dengue Outcome
Condition: Dengue
Intervention:
86 Completed Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease
Condition: Dengue Fever
Interventions: Biological: DENV-1 PIV, 2.5 µg;   Biological: DENV-1 PIV, 5 µg
87 Completed
Has Results
A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult Volunteers
Condition: Healthy
Interventions: Biological: Takeda's Tetravalent Dengue Vaccine Candidate (TDV);   Biological: TDV New Formulation;   Drug: Placebo;   Drug: New Formulation Placebo
88 Completed Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31‐7164) in Healthy Adults
Condition: Dengue Fever
Intervention: Biological: rDEN3delta30/31‐7164
89 Completed Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: rDEN1delta30;   Biological: Placebo
90 Completed Role of Andi-d in Dengue Fever: a Pilot Study
Condition: Dengue Fever
Intervention: Drug: anti-d
91 Completed Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults
Condition: Dengue
Interventions: Biological: rDEN3/4delta30(ME);   Biological: Placebo
92 Completed Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy Adults
Condition: Dengue
Interventions: Biological: rDEN4delta30-4995;   Biological: Placebo
93 Completed Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine - Admixture TV003;   Biological: TetraVax-DV Vaccine - Admixture TV005;   Biological: Placebo
94 Completed A Phase II Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand
Condition: Dengue
Interventions: Biological: T-DEN F17;   Biological: T-DEN F-19;   Other: Placebo Comparator
95 Completed Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine-Admixture 1;   Biological: TetraVax-DV Vaccine-Admixture 2;   Biological: TetraVax-DV Vaccine-Admixture 3;   Biological: TetraVax-DV Vaccine-Admixture 4;   Biological: Placebo;   Biological: TetraVax-DV Vaccine-Admixture 5
96 Completed Factors Associated With Poor Dengue Outcomes in Malaysia
Condition: Dengue Fever
Intervention:
97 Active, not recruiting A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)
Condition: Dengue Fever
Interventions: Biological: Biological/Vaccine: 4 µg TDENV-PIV with Alum adjuvant;   Biological: Biological/Vaccine: 1 µg TDENV-PIV with AS03B adjuvant;   Other: Phosphate buffered saline;   Biological: 1 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS01E adjuvant
98 Completed
Has Results
Safety and Immunogenicity Study to Assess TDV, a Live Attenuated Tetravalent Vaccine for Prevention of Dengue Fever
Condition: Dengue Fever
Interventions: Biological: TDV - Low Dose;   Biological: TDV - High Dose;   Biological: Placebo
99 Withdrawn Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever
Conditions: Dengue;   Disease Progression
Intervention: Other: diagnostic bedside ultrasound
100 Completed Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults
Condition: Dengue
Interventions: Biological: TV005;   Biological: Placebo;   Biological: rDEN2∆30-7169

First Page    Show previous page of results Previous Page (61-80) Studies Shown (81-100) Next Page (101-120) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.